FdaApplication
NDA 018709
Identifiers
- fda_app_no: NDA018709
Properties
| Property | Value |
|---|---|
| applicant_name | APOTHECON INC DIV BRISTOL MYERS SQUIBB |
| application_type | NDA |
| approval_date | 1984-10-12 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CAPOZIDE 25/15 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOZIDE 25/25 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOZIDE 50/15 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 50MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CAPOZIDE 50/25 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
4 products